4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-070467
Chief Executive Officer sold 60,000 shares at an average $67.56 ($4,053,431)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2021-12-15 | Sale | −25,857 | $66.28 | $1,713,802 | 3,253,165 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2021-12-15 | Sale | −14,857 | $67.19 | $998,242 | 3,238,308 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2021-12-15 | Sale | −3,074 | $68.20 | $209,647 | 3,235,234 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2021-12-15 | Sale | −9,223 | $69.52 | $641,183 | 3,226,011 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2021-12-15 | Sale | −6,989 | $70.19 | $490,558 | 3,219,022 | D |
| Open-market sales · 60,000 sh · avg $67.56 · $4,053,431 | |||||||
Loading xslF345X03/doc4.xml…